Fleischmann R, et al. A Phase 3, Randomized, Double-Blind Study Comparing Upadacitinib to Placebo and to Adalimumab, in Patients with Active Rheumatoid Arthritis with Inadequate Response to Methotrexate. ACR 2018, abstract 890.
Hoe mycofenolaatmofetil, azathioprine en tacrolimus hun weg vonden naar de reumatologie
feb 2020 | ILD, RA, Sclerodermie